CD40L is necessary for the priming of effector cells for lymphocytic and granulomatous experimental autoimmune thyroiditis

Journal of Autoimmunity

Volumn 12, Issue 1, 1999, Pages 1-12

  Peterson, Karin E ^a   Braley Mullen, Helen ^a,b  

^a University of Missouri   (United States)

^b WJB Dorn VA Medical Center   (United States)

Author keywords

Autoimmunity; CD40; EAT; T cell B cell collaboration

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CELL INTERACTION; FEMALE; HASHIMOTO DISEASE; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0033081958     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0256     Document Type: Article

References (39)

1. Banchereau J., Bazan F., Blanchard D., Brière F., Galizzi J.P., vanKooten C., Liu Y.J., Rousset F., Saeland S. 1994. The CD40 antigen and its ligand. Ann. Rev. Immunol 12: 881-922
2. + T cells. J. Immunol. 151: 2497-2510
3. Foy T.M., Aruffo A., Bajorath J., Buhlmann J., Noelle R.J. 1996. Immune regulation by CD40 and its ligand gp39. Ann. Rev. Immunol. 14: 591-617
4. Yang Y., Wilson J. 1996. CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40. Science 273: 1862-1864
5. Renshaw B.R., Fanslow III W.C., Armitage R.J., Campbell K.A., Liggitt D., Wright B., Davison B.L., Maliszewski C.R. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180: 1889-1900
6. Xu J., Foy T.M., Laman J.D., Elliott E.A., Dunn J., Waldschmidt T.J., Elsemore J., Noelle R.J., Flavell R.A. 1994. Mice deficient for the CD40 ligand. Immunity 1: 423-431
7. van Essen D., Kikutani H., Gray D. 1995. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378: 620-623
8. Grewal I.S., Xu J., Flavell R.A. 1995. Impairment of antigen-specific T cell priming in mice lacking CD40 ligand. Nature 378: 617-620
9. Grewal I.S., Foellmer H.G., Grewal K.D., Xu J., Hardardottir F., Baron J.L., Jr. Janeway C.A., Flavell R.A. 1996. Requirement for CD40 ligand in costimulation induction, T cell activation and experimental allergic encephalomyelitis. Science 273: 1864-1867
10. Stüber E., Strober W., Neurath M. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183: 693-698
11. Campbell K.A., Ovendale P.J., Kennedy M.K., Fanslow W.C., Reed S.G., Maliszewski C.R. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4: 283-289
12. Maruo S., Oh-hora M., Ahn H.J., Ono S., Wysocka M., Kaneko Y., Yagita H., Okumura K., Kikutani H., Kishimoto T., Kobayashi M., Hamaoka T., Trinchieri G., Fuiwara H. 1997. B cells regulate CD40 ligand-induced IL 12 production in antigen-presenting cells (APC) during T cell/APC interactions. J. Immunol. 158: 120-126
13. Desai-Mehta A., Lu L., Ramsey-Goldman R., Datta S.K. 1996. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97: 2063-2073
14. Gerritse K., Lamen J.D., Noelle R.J., Aruffo A., Ledbetter J.A., Boersma W.J., Claassen E. 1996. CD40-CD40 ligand interaction in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA 93: 2499-2504
15. Griggs N.D., Agersborg S.S., Noelle R.J., Ledbetter J.A., Linsley P.S., Tung K.S. 1996. The relative contribution of the CD28 and gp39 costimulatory pathways in the clonal expansion and pathogenic acquisition of self-reactive T cells. J. Exp. Med. 183: 801-810
16. Durie F.H., Fava R.A., Foy T.M., Aruffo A., Ledbetter J.A., Noelle R.J. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261: 1328-1330
17. Carayanniotis G., Masters S.R., Noelle R.J. 1997. Suppression of experimental autoimmune thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90: 421-426
18. Weigle W.O. 1980. Analysis of autoimmunity through experimental models of thyroiditis and allergic encephalomyelitis. Adv. Immunol. 30: 159-273
19. Braley-Mullen H., Johnson M., Sharp G.C., Kyriakos M. 1985. Induction of autoimmune thyroiditis in mice with in vitro activated splenic T cells. Cell. Immunol. 93: 132-143
20. McMurray R., Sharp G.C., Braley-Mullen H. 1994. Intrathyroidal cell phenotype in murine lymphocytic and granulomatous experimental autoimmune thyroiditis. Autoimmunity 18: 93-102
21. Braley-Mullen H., Sharp G.C., Bickel J.T., Kyriakos M. 1991. Induction of severe granulomatous experimental autoimmune thyroiditis in mice by effector cells activated in the presence of anti-interleukin 2 receptor antibody. J. Exp. Med. 173: 899-912
22. Braley-Mullen H., Sharp G.C., Tang H., Chen K., Kyriakos M., Bickel J.T. 1998. Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of experimental autoimmune thyroiditis. Am. J. Pathol. 152: 1347-1358
23. Stull S.J., Kyriakos M., Sharp G.C., Braley-Mullen H. 1988. Prevention and reversal of experimental autoimmune thyroiditis (EAT) in mice by administration of anti-L3T4 monoclonal antibody at different stages of disease development. Cell. Immunol. 117: 188-198
24. Romball G.C., Weigle W.O. 1987. Transfer of experimental autoimmune thyroiditis with T cell clones. J. Immunol. 138: 1092-1098
25. Vladutiu A.O. 1989. Experimental autoimmune thyroiditis in mice chronically treated from birth with anti-IgM antibodies. Cell. Immunol. 121: 49-59
26. Hutchings P., Rayner D.C., Champion B., Marshall-Clarke S., Macatonia S., Roitt I., Cooke A. 1987. High efficiency antigen presentation by thyroglobulin-primed murine splenic B cells. Eur. J. Immunol. 17: 393-398
27. Braley-Mullen H., Sharp G.C., Kyriakos M. 1994. Differential requirement for autoantibody-producing B cells for induction of lymphocytic vs. granulomatous experimental autoimmune thyroiditis. J. Immunol. 152: 307-314
28. Noelle R.J., Roy M., Shepherd D.M., Stamenkovic I., Ledbetter J.A., Aruffo A. 1992. A 39 kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA 89: 6550-6554
29. Tang H., Sharp G.C., Peterson K.E., Braley-Mullen H. 1998. Induction of granulomatous experimental autoimmune thyroiditis in IL4 gene disrupted mice. J. Immunol. 160: 155-162
30. Gaulton G.N., Bangs J., Maddock S., Springer T., Eardley D.D., Strom T.B. 1985. Characterization of a monoclonal rat anti-mouse interleukin-2 receptor antibody and its use in biochemical characterization of the murine interleukin-2 receptor. Clin. Immunol. Immunopathol. 36: 18-29
31. Williams W.V., Kyriakos M., Sharp G.C., Braley-Mullen H. 1986. The role of cellular proliferation in the induction of experimental autoimmune thyroiditis (EAT) in mice. Cell. Immunol. 103: 96-104
32. Tang H., Braley-Mullen H. 1997. Intravenous administration of deaggregated mouse thyroglobulin suppresses induction of experimental autoimmune thyroiditis and expression of both Th1 and Th2 cytokines. Internat. Immunol. 9: 679-687
33. Julius M.H., Simpson E., Herzenberg L.A. 1973. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 3: 645-649
34. Foy T.M., Shepherd D.M., Durie F.H., Aruffo A., Ledbetter J.A., Noelle R.J. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178: 1567-1575
35. Roy M., Aruffo A., Ledbetter J., Linsey P., Kehry M., Noelle R. 1995. Studies on the interdependence of gp9 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25: 596-603
36. Shinde S., Wu Y., Niu Q., Xu J., Grewal I.S., Flavell R., Liu Y. 1996. CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L. J. Immunol. 157: 2764-2768
37. Hathcock K.S., Laszlo G., Pucillo C., Linsley P., Hodes R.J. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: Expression and function. J. Exp. Med. 180: 631-640
38. + T cells but fail to produce IL12. Selective APC for Th2 development. Ann. NY Acad. Sci. 815: 401-411
39. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kämpen E., Romani N., Schuler G. 1996. High level IL12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J. Exp. Med. 184: 741-746